<DOC>
	<DOC>NCT00141570</DOC>
	<brief_summary>To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets</brief_summary>
	<brief_title>Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estrogens, Esterified (USP)</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<criteria>Menopausal women between the ages of 30 and 65 years (inclusive) with symptoms of estrogen and/or androgen deficiency not currently controlled by estrogen therapy as determined by patient report and the Investigator's clinical judgement</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Menopause; Postmenopause; Estrogen; Hormone Therapy</keyword>
</DOC>